Dr. Rosaline Kinuthia Clinical pharmacist KNH. Optimize patients outcomes through the judicious,...
-
Upload
jeffry-stephens -
Category
Documents
-
view
218 -
download
1
Transcript of Dr. Rosaline Kinuthia Clinical pharmacist KNH. Optimize patients outcomes through the judicious,...
• Optimize patients outcomes through the judicious, safe, efficacious, appropriate and cost effective use of medicines
• Should be engaged in all steps of the medicine use process
• The core of pharmacy activity involves: Supply of medication and other health care
products of assured quality Appropriate information and advice for the
patient Monitoring the effects of medicine use
204/19/23
Physiological changes due to acute stress affects disposition and response to drugs
- renal and hepatic blood flow, organ failure, protein binding etc
Large number of drugs hence increased interactions
Fluid restriction - consider in drug dilutions Drug incompatibilities and limited sites of
access Available dosage forms, intended use, gut
status, duration of action, urgency, hemodynamics
304/19/23
Management of medicine use Ensure an appropriate selection of
medicines is stocked and readily available
Ensure proper and safe storage of medicines and applicable nutritional products in and out of pharmacy
Review medication orders for appropriateness
404/19/23
Advise on drug reconstitution, dilution, rates of administration
Checking and advising on y-site or iv incompatibilities for iv medicines
Identify and advise on drug- drug, drug-disease, drug-nutrient interactions
Prevention, detection and correction of medication errors.
504/19/23
Monitoring patient therapy Medication history taking and relating that
with current patient’s condition/ treatment
Attend ward rounds and clinical meetings with other healthcare givers
Advising on suitability of therapy for individual patient based on lab results, organ function and risk to feotus, gestation etc
Culture results interpretation and advise on choice of antibiotic
604/19/23
Pharmacovigilance Monitoring adverse drug reactions and
poor quality medicines and reporting to relevant authorities
Provide drug and poison information to other medical practitioners and patients
Monitoring for efficacy and toxicity of medicines
704/19/23
Management of High alert medicines (HAMs)
HAMs bear higher risk of harm when used in error
Concentrated electrolytes, anticoagulants, inotropes, opioids
Processes for handling, admixtures, administration, monitoring
Awareness, safeguards, manage incidents
804/19/23
Neonatal pharmacotherapy Most drugs used in neonates are off - label High potential for errors due to small
doses/ unusual levels of dilution Mostly intravenous route - ensure
maximum bioavailability Immature liver/ renal function - slow
elimination, consider dose intervals Constant review of doses required TDM for narrow therapeutic index drugs
904/19/23
• Managing neonatal drug formulations
Advise on IV drug administration- dose, flow rates, appropriate concentrations, hypertonicity
Advise on reconstitution and dilutions for neonates. Ensure proper diluents and techniques to avoid errors.
Consider sterility and stability of iv preparations
Medicine manufacture and compounding - Alteration of dosage forms
- extemporaneous preps ( vehicle of use, crushing, mixing, stability of reconstituted drugs)
1004/19/23
Collaborate with nutritionist on appropriate pediatric nutrition formulations- volume, strength, content, monitoring, interactions
Formulation of policies and guidelines with other stakeholders
Conduct research and audits to improve service
Training on use of medicines Involved in infection control Manage emergency kits for specific obstetric
conditions
1104/19/23
• Inadequate staff levels• Availability of medicines especially pediatric
formulations/ off label prescribing• Non- formulary prescribing• Inadequate equipment and trained personnel• Lack of TDM facilities for low therapeutic index
drugs• Delays in procurement procedures• Manual record keeping
1204/19/23
Incorporate pharmacists into clinical teams
Involve pharmacists in development of policies and guidelines on patient care
Improve pharmacy infrastructure and equipment
Improve on compounding of drugs by providing appropriate equipment and staff - high alert medicines, nutritional supplements, neonatal formulations
1304/19/23
Automation of patient records for ease of reference and intervention
Provide appropriate medicine management software to reduce errors
Improve on staffing levels and appropriate deployment to ensure continuation of care
Offer TDM services
Neonatal formulary1404/19/23
FIP President , Sept 2008
“The goal must be that whenever and wherever medicines are discussed, a pharmacist must be WANTED and PRESENT”
1504/19/23